Ischemic stroke, which is caused by a sudden clot in the blood vessels, may cause severe
brain tissue damage and has become a leading cause of death globally. Currently …

Background Patients with malignancies have an increased risk of suffering ischemic stroke
via several mechanisms such as coagulation dysfunction and other malignancy‐related …

Aim NAMPT is a novel therapeutic target of ischemic stroke. The aim of this study was to
investigate the effect of a potential NAMPT activator, P7C3‐A20, an aminopropyl carbazole …

Clopidogrel is an antiplatelet drug used to reduce the risk of acute coronary syndrome and
stroke. It is converted by CYP2C19 to its active metabolite; therefore, poor metabolizers …

The efficacy and safety of anticoagulant therapy in patients with acute ischemic stroke (AIS)
and atrial fibrillation (AF) remain uncertain. This study enrolled 431 AIS and AF patients from …

Background The aim of this prospective study was to determine the prevalence of stenosis
within intracranial and extracranial arteries in patients before coronary artery bypass surgery …

Background Previous studies have shown high triglyceride (TG) is associated with platelet
hyperactivation in metabolic syndrome patients. However, limited information is available …

Anticoagulation therapy is critical to avoiding thrombotic events in patients following cranial
surgery. Although Aspirin, Plavix, and Aggrastat are used as anticoagulants for this purpose …

Thrombosis is the main cause of many cardiovascular diseases. The conventional
pharmaceuticals used for preventing thrombosis can induce significant adverse side effects …

Drugs targeting platelets play an important role in preventing or treating thrombotic events,
for example stroke and heart attack, thus increasing the life quality and expectancy of …